Literature DB >> 20079703

Unchanging clinico-epidemiological profile of lung cancer in north India over three decades.

Navneet Singh1, Ashutosh N Aggarwal, Dheeraj Gupta, Digambar Behera, Surinder K Jindal.   

Abstract

OBJECTIVE: In the recent past, adenocarcinoma has become the commonest histological type of lung cancer (LC) in the developed countries. The present study was conducted to assess the change in epidemiology of LC, if any, in North India.
METHODS: Prospectively collected data on 250 newly diagnosed LC patients presenting to a tertiary care institute was analyzed. Results were compared with the previously published data from this center.
RESULTS: No significant differences were observed in the demographical, histological or smoking profiles of LC patients compared to those seen three decades earlier. The mean [standard deviation] age was 57.9 [+/-11.3] years (previously 54.3 years). Male to female ratio was 4.43:1 (previously 4.48:1; p=0.952) while the smoker to non-smoker ratio was 2.67:1 (previously 2.68:1; p=0.980). The commonest histological types were squamous cell (34.8%), adenocarcinoma (26.0%) and small cell (18.4%) while previously these were 34.3%, 25.9% and 20.3%, respectively; p=0.916. However, in the present study, significant differences were observed between smokers and non-smokers in relation to distribution of gender, histology and disease stage.
CONCLUSIONS: There has been no significant change in the epidemiology of LC in North India over the past three decades. An absence of change in the smoking pattern of the population could be a possible reason.

Entities:  

Mesh:

Year:  2010        PMID: 20079703     DOI: 10.1016/j.canep.2009.12.015

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  23 in total

1.  Diagnostic utility of conventional transbronchial needle aspiration without rapid on-site evaluation in patients with lung cancer.

Authors:  Ritika Walia; Karan Madan; Anant Mohan; Deepali Jain; Vijay Hadda; Gopi C Khilnani; Randeep Guleria
Journal:  Lung India       Date:  2014-07

2.  Quantified smoking status and non-small cell lung cancer stage at presentation: analysis of a North Indian cohort and a systematic review of literature.

Authors:  Navneet Singh; Ashutosh N Aggarwal; Dheeraj Gupta; Digambar Behera; Surinder K Jindal
Journal:  J Thorac Dis       Date:  2012-10       Impact factor: 2.895

3.  Accelerated hypofractionated radiotherapy with concomitant chemotherapy in locally advanced squamous cell carcinoma of lung: evaluation of response, survival, toxicity and quality of life from a Phase II randomized study.

Authors:  Soumyajit Roy; Sushmita Pathy; Bidhu K Mohanti; Vinod Raina; Anand Jaiswal; Rakesh Kumar; Mani Kalaivani
Journal:  Br J Radiol       Date:  2016-03-17       Impact factor: 3.039

Review 4.  Erlotinib usage after prior treatment with gefitinib in advanced non-small cell lung cancer: A clinical perspective and review of published literature.

Authors:  Navneet Singh; Aditya Jindal; Digambar Behera
Journal:  World J Clin Oncol       Date:  2014-12-10

5.  Tumor cavitation among lung cancer patients receiving first-line chemotherapy at a tertiary care centre in India: association with histology and overall survival.

Authors:  Navneet Singh; Vamsi Krishna Mootha; Karan Madan; Ashutosh N Aggarwal; Digambar Behera
Journal:  Med Oncol       Date:  2013-05-15       Impact factor: 3.064

6.  Pleural tuberculosis following lung cancer chemotherapy: a report of two cases proven pathologically by pleural biopsy.

Authors:  Karan Madan; Navneet Singh; Ashim Das; Digambar Behera
Journal:  BMJ Case Rep       Date:  2013-01-22

7.  An Immunohistochemical Study of Anaplastic Lymphoma Kinase and Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Carcinoma.

Authors:  Sonal Verma; Madhu Kumar; Malti Kumari; Raj Mehrotra; R A S Kushwaha; Madhumati Goel; Ashutosh Kumar; Surya Kant
Journal:  J Clin Diagn Res       Date:  2017-07-01

8.  Extrapulmonary small cell carcinoma of lymph node: Pooled analysis of all reported cases.

Authors:  Inderpaul Singh Sehgal; Harpreet Kaur; Sahajal Dhooria; Amanjit Bal; Nalini Gupta; Digambar Behera; Navneet Singh
Journal:  World J Clin Oncol       Date:  2016-06-10

9.  Utility of the revised Edmonton Symptom Assessment System (ESAS-r) and the Patient-Reported Functional Status (PRFS) in lung cancer patients.

Authors:  M N Yogananda; Valliappan Muthu; Kuruswamy Thurai Prasad; Adarsh Kohli; Digambar Behera; Navneet Singh
Journal:  Support Care Cancer       Date:  2017-10-12       Impact factor: 3.603

10.  Extensive-disease small cell lung cancer, multiple relapses, five lines of therapy and more than 10-year survival.

Authors:  Pawan Kumar Singh; Deepa Kumari Shrestha; Navneet Singh; Nalini Gupta
Journal:  BMJ Case Rep       Date:  2020-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.